NAUT · Forms 3, 4, 5
Insider trades at Nautilus Biotechnology, Inc.
No open-market insider buys or sells at Nautilus Biotechnology, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Nautilus Biotechnology, Inc. (NAUT) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Nautilus Biotechnology, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Matthew L. Posard | Director | Options or other derivatives | Form 4 | ||||
| Farzad Nazem | Director | Options or other derivatives | Form 4 | ||||
| Karen Akinsanya | Director | Options or other derivatives | Form 4 | ||||
| Matthew S McIlwain | Director | Options or other derivatives | Form 4 | ||||
| Epperly Melissa B, | Director | Options or other derivatives | Form 4 | ||||
| AH Equity Partners Bio II, L.L.C. | 10% owner | Sell | 4,615,974 | $2.35 | $10.8M | Form 4 | |
| AH Equity Partners Bio II, L.L.C. | 10% owner | Sell | 384,026 | $2.35 | $902K | Form 4 | |
| Sujal M Patel | CEO, President, and Secretary | Buy | 25,000 | $2.61 | $65K | Form 4 | |
| Anna Mowry | CFO and Treasurer | Options or other derivatives | Form 4 | ||||
| Parag Mallick | Chief Scientist | Options or other derivatives | Form 4 | ||||
| Sujal M Patel | CEO, President, and Secretary | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.